{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:31:08Z","timestamp":1787783468755,"version":"build-2784847793"},"reference-count":47,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department for International Development, UK (DFID)"},{"name":"National Health Foundation, Brazil (FUNASA)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.vaccine.2014.05.042","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T11:30:09Z","timestamp":1400585409000},"page":"3759-3764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Causes of variation in BCG vaccine efficacy: Examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses"],"prefix":"10.1016","volume":"32","author":[{"given":"Mauricio L.","family":"Barreto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pilger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Genser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro A.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio S.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemax","family":"Sant\u2019Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Hijjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Y.","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.05.042_bib0005","series-title":"Tuberculosis in the UK: annual report on tuberculosis surveillance in the UK","author":"Health Protection Agency Centre for Infections","year":"2010"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm0211-159","article-title":"Tuberculosis vaccines\u2014a new kid on the block","volume":"17","author":"Kaufmann","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0015","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0020","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0025","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0140-6736(10)60393-5","article-title":"New vaccines for tuberculosis","volume":"375","author":"Kaufmann","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0264-410X(02)00447-4","article-title":"A novel TB vaccine; towards a strategy based on our understanding of BCG failure","volume":"21","author":"Agger","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0035","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.1184784","article-title":"Tuberculosis: what we don\u2019t know can, and does, hurt us","volume":"328","author":"Russell","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0040","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0045","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0140-6736(13)60137-3","article-title":"A major event for new tuberculosis vaccines","volume":"381","author":"Dye","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0050","doi-asserted-by":"crossref","first-page":"20130365","DOI":"10.1098\/rsif.2013.0365","article-title":"Making wider use of the world's most widely used vaccine: bacille Calmette-Guerin revaccination reconsidered","volume":"10","author":"Dye","year":"2013","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0055","series-title":"Issues relating to the use of BCG in immunization programmes","author":"Fine","year":"1999"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0060","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0140-6736(90)91074-K","article-title":"Modern vaccines. Mycobacterial diseases","volume":"335","author":"Fine","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0065","first-page":"1","article-title":"Protective effect of BCG in experimental tuberculosis","volume":"22","author":"Smith","year":"1985","journal-title":"Adv Tuberc Res"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0075","first-page":"276","article-title":"Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination","volume":"91","author":"Comstock","year":"1976","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0080","first-page":"819","article-title":"Trial of BCG vaccines in South India for tuberculosis prevention","volume":"57","author":"Tuberculosis Prevention Trial","year":"1979","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-3083.1979.tb02713.x","article-title":"Cross-reactions between mycobacteria. II. Crossed immunoelectrophoretic analysis of soluble antigens of BCG and comparison with other mycobacteria","volume":"9","author":"Harboe","year":"1979","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0090","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0095","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/IAI.73.4.2190-2196.2005","article-title":"Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens","volume":"73","author":"Demangel","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0100","first-page":"201","article-title":"Immune response & modulation of immune response induced in the guinea-pigs by Mycobacterium avium complex (MAC) & M. fortuitum complex isolates from different sources in the south Indian BCG trial area","volume":"103","author":"Kamala","year":"1996","journal-title":"Indian J Med Res"},{"issue":"6","key":"10.1016\/j.vaccine.2014.05.042_bib0105","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1183\/09031936.00149212","article-title":"The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: a NTM-NET collaborative study","volume":"42","author":"Hoefsloot","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0110","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG\u2014implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0115","first-page":"553","article-title":"Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis","volume":"94","author":"Palmer","year":"1966","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0120","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-3083.1997.d01-99.x","article-title":"Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group","volume":"46","author":"Lozes","year":"1997","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0130","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1473-3099(11)70285-7","article-title":"Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial","volume":"12","author":"Pereira","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0140","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","article-title":"Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial","volume":"29","author":"Barreto","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0145","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0197-2456(02)00216-7","article-title":"Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age","volume":"23","author":"Barreto","year":"2002","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0150","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1590\/S0034-89102003000200015","article-title":"Sensitivity and specificity of the BCG scar reading","volume":"37","author":"Pereira","year":"2003","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0155","first-page":"1067","article-title":"Sensitivity and specificity of BCG scar reading in Brazil","volume":"5","author":"Pereira","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0160","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0264-410X(02)00721-1","article-title":"BCG (Bacille of Calmette-Guerin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children","volume":"21","author":"Barbosa","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0165","first-page":"656","article-title":"Skin test reactivity to mycobacterial antigens parallels the phylogenetic structure of their genus","volume":"5","author":"Bierrenbach","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0170","first-page":"399","article-title":"Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren","volume":"7","author":"Dourado","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0175","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1371\/journal.pntd.0000167","article-title":"BCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trial","volume":"2","author":"Cunha","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ije\/17.1.193","article-title":"Risk assessment for acquiring meningitis tuberculosis among children not vaccinated with BCG: a case\u2013control study","volume":"17","author":"Camargos","year":"1988","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0185","first-page":"26","article-title":"Protective effect of intradermal BCG against tubercular meningitis","volume":"110","author":"Nascimento-Costa","year":"1991","journal-title":"Bol Oficina Sanit Panam"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0190","first-page":"69","article-title":"Effectiveness of BCG vaccination against tuberculous meningitis: a case-control study in Sao Paulo, Brazil","volume":"68","author":"Wunsch Filho","year":"1990","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0195","first-page":"229","article-title":"Statement on BCG revaccination for the prevention of tuberculosis","volume":"70","author":"Global Programme on Tuberculosis","year":"1995","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0200","series-title":"Programa Nacional De Controle Da Tuberculose (PNCT)","author":"Ministerio da Saude","year":"2011"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0205","first-page":"1171","article-title":"Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil","volume":"9","author":"Barreto","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0215","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies","volume":"359","author":"Black","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0220","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/IAI.65.8.3317-3327.1997","article-title":"Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection","volume":"65","author":"Hernandez-Pando","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0225","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0264-410X(01)00436-4","article-title":"Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis","volume":"20","author":"Buddle","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tube.2004.09.007","article-title":"The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium","volume":"85","author":"de Lisle","year":"2005","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2014.05.042_bib0235","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"Abu-Raddad","year":"2009","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14007099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14007099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T21:10:27Z","timestamp":1649020227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14007099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":47,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0264410X14007099"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Causes of variation in BCG vaccine efficacy: Examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}